Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tetracycline 2.2mg/ml topical solution
1306010W0AAAAAA
|
Tetracycline (Acne) | Tetracycline hydrochloride | Skin | No data available |
|
Thwart 26% solution
1307000M0BYAABA
|
Thwart | Salicylic acid | Skin | No data available |
|
Tildrakizumab 100mg/1ml inj pre-filled syringes
1305030H0AAAAAA
|
Tildrakizumab | Tildrakizumab | Skin | No data available |
|
Tildrakizumab 200mg/2ml inj pre-filled syringes
1305030H0AAABAB
|
Tildrakizumab | Tildrakizumab | Skin | No data available |
|
Tinaderm 1% cream
1310020Y0BBAAAA
|
Tinaderm | Tolnaftate | Skin | No data available |
|
Tinaderm Plus 1% powder
1310020Y0BBAEAB
|
Tinaderm | Tolnaftate | Skin | No data available |
|
Tinaderm-M cream
1310020U0BEAAAG
|
Tinaderm-M | Nystatin | Skin | No data available |
|
Toepedo cream
1310020V0BEAAAD
|
Toepedo | Salicylic acid | Skin | No data available |
|
Tolnaftate 0.12% spray
1310020Y0AAAKAK
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Benzalkonium chloride 0.1% cream
1310020Y0AAALAL
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Benzalkonium chloride 0.1% ointment
1310020Y0AAAGAG
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Chlorhexidine 0.25% powder
1310020Y0AAAHAH
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% cream
1310020Y0AAAAAA
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% dry powder spray
1310020Y0AAAJAJ
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Topicycline 2.2mg/ml topical solution
1306010W0BBAAAA
|
Topicycline | Tetracycline hydrochloride | Skin | No data available |
|
Torbetol acne lotion
1311020L0CEAAA0
|
Torbetol (Topical) | Chlorhexidine gluconate | Skin | No data available |
|
Tralokinumab 150mg/1ml inj pre-filled syringes
1305030J0AAAAAA
|
Tralokinumab | Tralokinumab | Skin | No data available |
|
Tralokinumab 300mg/2ml inj pre-filled disposable devices
1305030J0AAABAB
|
Tralokinumab | Tralokinumab | Skin | No data available |
|
Tremfya 100mg/1ml solution for injection pre-filled pens
1305030F0BBABAB
|
Tremfya | Guselkumab | Skin | No data available |
|
Tremfya 100mg/1ml solution for injection pre-filled syringes
1305030F0BBAAAA
|
Tremfya | Guselkumab | Skin | No data available |
|
Tretinoin 0.025% lotion
1306010V0AAACAC
|
Tretinoin (Acne) | Tretinoin | Skin | No data available |
|
Tretinoin 0.1% gel
1306010V0AAAPAP
|
Tretinoin (Acne) | Tretinoin | Skin | No data available |
|
Tri-Adcortyl cream
1304000Z0BGABCE
|
Tri-Adcortyl (Topical) | Triamcinolone acetonide | Skin | No data available |
|
Tri-Adcortyl ointment
1304000Z0BGACCJ
|
Tri-Adcortyl (Topical) | Triamcinolone acetonide | Skin | No data available |
|
Tri-Luma cream
131500000BBNAA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.